About Magnetic Insight Inc. - MagneticInsight

来自 : 发布时间：2024-11-19

About Magnetic Insight Inc. Magnetic Insight, leader in Magnetic Particle Imaging (MPI), represents one of the most powerful approaches to preclinical imaging in the last 20 years with translation to the clinic. MPI harnesses nanotechnology in imaging and therapy with a direct bridge to the complete cell therapy workflow and development.Magnetic Particle Imaging is ground-breaking technology that will overcome major deficiencies with current clinical and translational research imaging techniques.Magnetic Insight Inc. was founded by one of the leading research groups in the global field of Magnetic Particle Imaging from UC Berkeley. Executive Leadership Anna Christensen, PhD CEO, Co-founder

Dr Christensen has spent the last 16 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc and Caliper Life Sciences as the global business leader. Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices. In addition to her commercial experience, she holds advanced degrees in cell biology and neurobiology from UC San Diego and Copenhagen University.

Anna Christensen, PhD

CEO, Co-founder

Patrick Goodwill, PhD CTO, Co-founder

Dr. Goodwill has spent the last 9 yearsleading the development team in MagneticParticleImagingat UCBerkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images. Dr. Goodwill hasa PhD in Bioengineering from UC Berkeley, and aB.S. and M.S. in ElectricalEngineering fromStanfordUniversity.Prior to UC Berkeley, Dr. Goodwill designedmicroprocessors at Intel Corporation.

Patrick Goodwill, PhD CTO, Co-founder David Panzarella CCO, Magnetic Insight

Mr. Panzarella has over 12 years of experience within research imaging, leading the global commercial infrastructure which included sales, service, field applications and customer support for PerkinElmer, Caliper Life Sciences and Xenogen. He has become a cornerstone within preclinical imaging in developing strategic customer partnerships while setting the bar for technology support within the imaging community. Prior to joining Xenogen, he held commercial positions with Biospace, Cerner, WebMD and Critikon (a J&J company). He has a BS degree in Marketing and Business Administration from Wright State University and an MBA in Finance from the Hagan School of Business at Iona College.

David Panzarella

CCO, Magnetic Insight

The Board Anna Christensen, PhD CEO, Co-founder

Dr Christensen has spent the last 16 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc and Caliper Life Sciences as the global business leader. Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices. In addition to her commercial experience, she holds advanced degrees in cell biology and neurobiology from UC San Diego and Copenhagen University.

Anna Christensen, PhD

CEO, Co-founder

Patrick Goodwill, PhD CTO, Co-founder

Dr. Goodwill has spent the last 9 yearsleading the development team in MagneticParticleImagingat UCBerkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images. Dr. Goodwill hasa PhD in Bioengineering from UC Berkeley, and aB.S. and M.S. in ElectricalEngineering fromStanfordUniversity.Prior to UC Berkeley, Dr. Goodwill designedmicroprocessors at Intel Corporation.

Patrick Goodwill, PhD

CTO, Co-founder

Weijia (Victor) Wang CEG Ventures Weijia (Victor) Wang

AimTop Ventures

Joe Victor CEO of Rarecyte

Joe Victor, CEO of Rarecyte and serial entrepreneur is on his 3rd company breaking the mold in various areas of life science solutions. He is a seasoned veteran in growing startups into organizations with $100M in revenue.

Joe Victor CEO of Rarecyte David Allison Partner at 5AM Ventures

David Allison, Partner at 5AM Ventures with a PhD in Biomedical Engineering from Rice University has lead numerous HealthTech investments to success in the last 14 years.

David Allison

Partner at 5AM Ventures

The Advisors Mike Harsh Commercial Advisor, CTO GE Healthcare

Mr. Michael (Mike) Harsh is co-founder of Terapede Systems with over 36 years’ experience in healthcare technology, focused on diagnostic imaging. He served as Vice President and Chief Technology Officer for GE Healthcare, a $17 billion division of General Electric. As the Global Technology Leader of Imaging Technologies at GE Global Research, he led the research for X-Ray, CT, MRI, Ultrasound, Nuclear Medicine, PET and Optical Imaging, and the research associated with computer visualization/image analysis and superconducting systems. Mike was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, for his significant contributions to the medical and biological engineering field. Additionally, Mike holds numerous U.S. patents in the field of Medical Imaging and Instrumentation. Mike received a bachelor’s degree in Electrical Engineering from Marquette University, Milwaukee, Wisconsin, and he is a member of the University of Wisconsin Madison Industrial Advisory Board to the College of Engineering.

Mike Harsh Commercial Advisor, CTO GE Healthcare Steven Conolly, PhD Co-founder, MPI Professor at UC Berkeley

Prof. Conolly is a the Montford Cook Professor of Bioengineering, Electrical Engineering, and Computer Science at the University of California Berkeley. He received his Ph.D. in Electrical Engineering from Stanford University, where he developed new types of MRI scanners for over twenty years. At Berkeley he has applied his knowledge of building new imaging systems to MPI. He has a history of innovation, and for his many inventions, he was named one of only 24 people named a Stanford Outstanding Inventor.

Steven Conolly, PhD Co-founder, MPI Professor at UC Berkeley Max Wintermark MD Medical Advisor, Chief Neuroradiology Stanford

Dr. Wintermark is currently a Professor of Radiology and the Chief of Neuroradiology at the Stanford University. His specific interest and expertise is in stroke, traumatic brain injury, epilepsy, movement disorders and psychiatric disorders. He chairs on the research committees for the American Society of Neuroradiology (ASNR), American Society of Functional Neuroradiology (ASFNR) and the imaging working group of the NINDS-funded stroke clinical trial network (StrokeNET).

Max Wintermark MD Medical Advisor, Chief Neuroradiology Stanford Craig Coombs, PhD Regulatory Advisor, The FDA Navigator, Medtronics

Craig Coombs has been the head of Coombs Medical Device Consulting since 1998. His group specializes in hands-on, innovative, US and European regulatory strategies for start-ups and companies that need to change their business strategies. Their skills also include cost-effective first-in-man or VC milestone clinical trial design, management and analysis. Mr. Coombs received his BS in Biology from Stanford University. He is a former Vice President of Medtronic in the areas of Regulatory Affairs, Quality Assurance and Clinical Studies. Mr. Coombs is adjunct faculty for the University of California (Santa Cruz) in Medical Device Submissions and a frequently invited speaker at industry and government regulatory affairs seminars.

Craig Coombs, PhD Regulatory Advisor, The FDA Navigator, Medtronics Interested in partnering or investment opportunites? E-MAIL US

Magnetic Insight, Inc.1010 Atlantic Ave. Suite 100Alameda CA 94501 USA

Tel: +1 510 291 1200

Email:info@magneticinsight.com

CookiesTo make this site work properly, we sometimes place small data files called cookies on your device.